{"altmetric_id":4862359,"selected_quotes":["$TCON Phase 2 trial w\/est Apr completion date NCT02396511: Trial Tracker","$TCON Phase 2 trial w\/est Dec completion date NCT02396511: Trial Tracker"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["Tracon Pharmaceuticals Inc."],"first_seen_on":"2015-12-10T14:07:40+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1459861508,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02396511"],"nct_id":"NCT02396511","pubdate":"2015-03-05T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Single Patient Treatment Protocol of TRC105 Combined With Standard-dose Bevacizumab for a Single Patient With Metastatic And Refractory Choriocarcinoma","type":"clinical_trial_study_record"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":7499955,"mean":6.4950193838481,"rank":5676233,"this_scored_higher_than_pct":13,"this_scored_higher_than":1003813,"rank_type":"exact","sample_size":7499955,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":293288,"mean":8.8543337959062,"rank":201793,"this_scored_higher_than_pct":16,"this_scored_higher_than":49501,"rank_type":"exact","sample_size":293288,"percentile":16},"this_journal":{"total_number_of_other_articles":19645,"mean":9.9780873549175,"rank":13312,"this_scored_higher_than_pct":13,"this_scored_higher_than":2715,"rank_type":"exact","sample_size":19645,"percentile":13},"similar_age_this_journal_3m":{"total_number_of_other_articles":942,"mean":16.317043570669,"rank":638,"this_scored_higher_than_pct":9,"this_scored_higher_than":90,"rank_type":"exact","sample_size":942,"percentile":9}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}},"geo":{"twitter":{"US":1}}},"counts":{"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["fda_tracker"],"posts_count":2}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/fda_tracker\/statuses\/674953031574618113","license":"gnip","citation_ids":[4862359],"posted_on":"2015-12-10T14:05:17+00:00","author":{"name":"FDA Tracker","url":"http:\/\/www.fdatracker.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1667207308\/square_logo_normal.png","description":"Analytics for Pharma and Biotech Traders","id_on_source":"fda_tracker","tweeter_id":"391492257","geo":{"lt":37.77493,"ln":-122.41942,"country":"US"},"followers":2946},"tweet_id":"674953031574618113"},{"url":"http:\/\/twitter.com\/fda_tracker\/statuses\/717337275097460736","license":"gnip","citation_ids":[4862359],"posted_on":"2016-04-05T13:05:08+00:00","author":{"name":"FDA Tracker","url":"http:\/\/www.fdatracker.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1667207308\/square_logo_normal.png","description":"Analytics for Pharma and Biotech Traders","id_on_source":"fda_tracker","tweeter_id":"391492257","geo":{"lt":37.77493,"ln":-122.41942,"country":"US"},"followers":2946},"tweet_id":"717337275097460736"}]}}